Sudha Sravanti Kotapalli

Statistics

Publications

Citations

391

H-Index

Active since

2014

Affiliations

Indian Institute of Chemical Technology(Current)

Jawaharlal Nehru Technological University, Hyderabad

Academy of Scientific and Innovative Research

Birla Institute of Technology and Science, Pilani

Sudha Sravanti Kotapalli is an author at Indian Institute of Chemical Technology specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

2014–2018

Publications

Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents

Narender Reddy Emmadi, Chiranjeevi Bingi, Sudha Sravanti Kotapalli et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 56 citations

Medicine, Medicinal Chemistry, Microbiology +14

Synthesis, in vitro anticancer and antimycobacterial evaluation of new 5-(2,5-dimethoxyphenyl)-1,3,4-thiadiazole-2-amino derivatives

Naveen Polkam, Parsharamulu Rayam, Jaya Shree Anireddy et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 55 citations

Pharmacy, Medicinal Chemistry, Oncology +14

Investigation of triazole-linked indole and oxindole glycoconjugates as potential anticancer agents: novel Akt/PKB signaling pathway inhibitors

Atulya Nagarsenkar, Santosh Kumar Prajapti, Sravanthi Devi Guggilapu et al. · MedChemComm · 2016 · 50 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Oxazolidinone derivatives: Cytoxazone–Linezolid hybrids induces apoptosis and senescence in DU145 prostate cancer cells

Annavareddi Naresh, M. V. Basaveswara Rao, Sudha Sravanti Kotapalli et al. · European Journal of Medicinal Chemistry · 2014 · 46 citations

Medicine, Oncology, Pharmacology +6

Synthesis and biological screening of 2′-aryl/benzyl-2-aryl-4-methyl-4′,5-bithiazolyls as possible anti-tubercular and antimicrobial agents

Yogita Abhale, Amit V. Sasane, Abhijit Chavan et al. · European Journal of Medicinal Chemistry · 2015 · 38 citations

Pharmacy, Medicinal Chemistry, Pharmacology +5

1–5 of 11